An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012

by Lee JSF, Teyssier LS, Nguimfack BD, Collins IJ, Lallemant M, Perriens J and Moatti JP. BMC Pediatrics 2016, 16:41. doi:10.1186/s12887-016-0578-x

Summary: The pediatric antiretroviral (ARV) market is poorly described in the literature, resulting in gaps in understanding treatment access. We analyzed the pediatric ARV market from 2004 to 2012 and assessed pricing trends and associated factors. The  study found that the donor funded pediatric ARV market as represented by the Global Price Reporting Mechanism (GPRM) database is small, and lacks price competition. It is dominated by generic drugs due to the lower prices offered and the practicality of fixed dose combination formulations. This market requires continued donor support and the current initiatives to protect it are important to ensure market viability, especially if new formulations are to be introduced in the future.

Click here to read the article / PDF